Peripheral neuropathy Board decisions

The Board granted service connection for diabetes mellitus type II but denied service connection for left upper extremity, right upper extremity, left lower extremity, and right lower extremity diabetic peripheral neuropathy.

The Board denied the veteran's claims for increased ratings and earlier effective dates, as the evidence did not support a higher rating or an earlier effective date.

The Board granted a 70 percent rating for major depressive disorder from January 31, 2020, and denied ratings in excess of 30 percent prior to that date. The Board also granted a 30 percent rating for left and right lower extremity peripheral neuropathy starting May 12, 2021.

The Board denied a compensable rating for lumbar spine surgical scars and a rating in excess of 50 percent for PTSD, while remanding the claims for increased ratings for left shoulder strain with AC joint osteoarthritis, ulnar neuropathy of the left upper extremity, and lumbar spinal stenosis, degenerative arthritis, and degenerative disc disease.

The Board remands the claim for service connection of a right eye condition to correct pre-decisional duty to assist errors and provide additional notice.

The Board remands the claims for service connection for coronary artery disease with hypertension and congestive heart failure, diabetes mellitus type II, peripheral neuropathy, upper and lower extremities, bilateral hearing loss, and tinnitus due to a need for further development including obtaining records in the possession of the federal government and obtaining an adequate medical opinion.

The Board granted increased ratings for the Veteran's left and right upper extremity neuropathy, but denied increased ratings for the lower extremities.

The Board denied service connection for diabetic neuropathy of the left upper, lower extremities and right lower extremity. The claims were remanded for further development regarding cardiovascular arterial disease and carpal tunnel of the right wrist.

The Board remands the claims for service connection for ischemic heart disease, chronic lymphocytic leukemia, peripheral neuropathy of the bilateral lower extremities, and posttraumatic stress disorder due to insufficient evidence regarding the Veteran's claimed exposure to herbicide agents in Vietnam or Korea.

The Board remands the issues of entitlement to increased ratings for peripheral neuropathy affecting both upper and lower extremities due to new evidence that was not previously considered.

The Board granted service connection for bilateral upper extremity peripheral neuropathy and bilateral lower extremity peripheral neuropathy, finding that the Veteran's symptoms are due to in-service exposure to herbicide agents.

The Board granted an effective date of August 10, 2022, for service connection for right and left lower extremity peripheral neuropathy associated with TERA participation.

The Board denied service connection for left and right ulnar nerve entrapment neuropathy, right foot hallux valgus, and left foot hallux valgus. The claim for bilateral pes planus was remanded.

The Board denied service connection for coronary artery disease and remanded the claims for peripheral arterial disease, left leg; peripheral arterial disease, right leg; and peripheral neuropathy, both left and right legs.

The Board granted eligibility for attorney fees based on the past-due benefits awarded in October 2022, including a 100 percent rating for PTSD and related conditions, but denied such fees for other benefits.

The appeal for an earlier effective date for the grant of service connection for left and right lower extremity diabetic peripheral neuropathy was dismissed due to it being a duplicate of appeals under separate docket numbers that were previously denied.

The Board granted service connection for costochondritis, peripheral neuropathy of the left upper and lower extremities, and restless leg syndrome, all secondary to the Veteran's service-connected PTSD with panic attacks and substance abuse. The claims for fibromyalgia and menorrhagia were denied.

The Board denied service connection for hypothyroidism and peripheral neuropathy in the left, right, lower, and upper extremities as there is no evidence linking these conditions to the Veteran's military service.

The appeal was dismissed as the Veteran withdrew all claims, including the instant appeal, on January 27, 2025.

The Board remands the claims for a new VA examination and to obtain private treatment records as the previous VA examination was incomplete and did not fully address all pertinent findings.